Skip to main content

Verley takes precision-fermented whey protein to 200,000-litre tanks, with commercial sales set for 2027

The Lyon company is running beta-lactoglobulin at 200 cubic metres at a co-manufacturer and says it already matches Arla's price for the dairy-extracted

Verley takes precision-fermented whey protein to 200,000-litre tanks, with commercial sales set for 2027

Verley, the Lyon precision fermentation company formerly called Bon Vivant, is producing beta-lactoglobulin in 200 cubic metre tanks and plans to begin commercial sales next year. Cofounder and chief executive Stéphane Mac Millan set out the position in an interview published by AgFunderNews on 6 October 2026: "Right now, we are doing 200 cubic meter (200,000-L) tank fermentation." The company closed a €32 million Series A in February 2026, led by Alven, with Blast, the French Tech Seed fund managed by Bpifrance under France 2030, Sofinnova, Sparkfood, Captech and Founders Future participating.

Beta-lactoglobulin, or BLG, is the whey protein that carries the functional behaviour food companies want: it stays soluble and clear at low pH and under heat, which is what lets a drink hold a high protein load without turning to chalk. Verley sells it as FermWhey Native, a 95 per cent BLG whey protein, and FermWhey MicroStab, a microparticulated and functionalised version. Mac Millan puts the application count at more than 20 across food and beverage, and gives two concrete formulation numbers: 25 grams of protein in a 100-millilitre shot, and UHT drinkable yogurt that he says is "capped at 9% protein [by weight] at the very best" taken as high as 13 per cent.

The price comparison is the part that distinguishes this from most precision fermentation announcements. Mac Millan says Arla is extracting BLG from milk and selling it "at more than $40 per kg, and that's the same price as us", which places Verley at parity with the incumbent dairy route rather than at a premium to it. On the regulatory side the company obtained a GRAS no-questions letter in the United States in September 2025, the first for functionalised dairy proteins made by precision fermentation. Canada is pending. For Europe, Mac Millan expects approval via the novel foods process "in the next two to three years". Commercially the company is aimed at North America, Europe and the GCC.

What is left to solve is downstream processing, the purification step after the fermenter. "The DSP is what you call purification after fermentation: how do you extract the exact protein, and only the protein [from the fermentation broth]?" Mac Millan said, adding that "the idea is to recover as much as 100% [of the protein produced] if possible". He expects to finalise that work in the coming months and to start commercialising next year. The 200 cubic metre runs are at a co-manufacturer rather than in an owned plant.

Why it matters for AgTech founders: the headline number here is not the tank size, it is the $40 per kilo. Precision fermentation has spent a decade selling cost curves that converge on parity at some future scale, and the companies that survived the 2024-2025 funding correction are the ones that stopped promising commodity economics and went after a protein where the incumbent price is already high because the incumbent process is already hard. BLG extracted from milk is a low-yield, high-value fraction, which is why Arla can charge above $40 and why a fermentation route only has to be good, not miraculous. Two things follow for anyone building in biomanufacturing. First, pick the molecule by the incumbent's cost structure, not by market size; a €40-plus per kilo entry point buys you the right to be imperfect at 200 cubic metres, where a €4 per kilo target does not. Second, the binding constraint moves from the fermenter to downstream processing far earlier than most plans assume, and DSP yield is where margin is made or lost. Verley is doing this at a co-manufacturer rather than building its own plant, which is the correct capital decision and also a reminder that European tankage of this size is a scarce, contracted resource: founders who have not secured co-man capacity in writing before raising their scale-up round are negotiating from the weaker side. The regulatory split is worth noting too. US clearance in hand, Europe two to three years out, so the home market is the last one to open. That sequencing is now normal for European novel-food deep tech, and it should be in the plan rather than a surprise in the board pack.

Source: AgFunderNews

Verley takes precision-fermented whey protein to 200,000-litre tanks, with commercial sales set for 2027

The Lyon company is running beta-lactoglobulin at 200 cubic metres at a co-manufacturer and says it already matches Arla's price for the dairy-extracted protein at more than $40 per kilo.

By Dirk Vandenhirtz

· Deep Tech · Europe · 4 min

Verley, the Lyon precision fermentation company formerly called Bon Vivant, is producing beta-lactoglobulin in 200 cubic metre tanks and plans to begin commercial sales next year. Cofounder and chief executive Stéphane Mac Millan set out the position in an interview published by AgFunderNews on 6 October 2026: "Right now, we are doing 200 cubic meter (200,000-L) tank fermentation." The company closed a €32 million Series A in February 2026, led by Alven, with Blast, the French Tech Seed fund managed by Bpifrance under France 2030, Sofinnova, Sparkfood, Captech and Founders Future participating.

Beta-lactoglobulin, or BLG, is the whey protein that carries the functional behaviour food companies want: it stays soluble and clear at low pH and under heat, which is what lets a drink hold a high protein load without turning to chalk. Verley sells it as FermWhey Native, a 95 per cent BLG whey protein, and FermWhey MicroStab, a microparticulated and functionalised version. Mac Millan puts the application count at more than 20 across food and beverage, and gives two concrete formulation numbers: 25 grams of protein in a 100-millilitre shot, and UHT drinkable yogurt that he says is "capped at 9% protein [by weight] at the very best" taken as high as 13 per cent.

The price comparison is the part that distinguishes this from most precision fermentation announcements. Mac Millan says Arla is extracting BLG from milk and selling it "at more than $40 per kg, and that's the same price as us", which places Verley at parity with the incumbent dairy route rather than at a premium to it. On the regulatory side the company obtained a GRAS no-questions letter in the United States in September 2025, the first for functionalised dairy proteins made by precision fermentation. Canada is pending. For Europe, Mac Millan expects approval via the novel foods process "in the next two to three years". Commercially the company is aimed at North America, Europe and the GCC.

What is left to solve is downstream processing, the purification step after the fermenter. "The DSP is what you call purification after fermentation: how do you extract the exact protein, and only the protein [from the fermentation broth]?" Mac Millan said, adding that "the idea is to recover as much as 100% [of the protein produced] if possible". He expects to finalise that work in the coming months and to start commercialising next year. The 200 cubic metre runs are at a co-manufacturer rather than in an owned plant.

Why it matters for AgTech founders: the headline number here is not the tank size, it is the $40 per kilo. Precision fermentation has spent a decade selling cost curves that converge on parity at some future scale, and the companies that survived the 2024-2025 funding correction are the ones that stopped promising commodity economics and went after a protein where the incumbent price is already high because the incumbent process is already hard. BLG extracted from milk is a low-yield, high-value fraction, which is why Arla can charge above $40 and why a fermentation route only has to be good, not miraculous. Two things follow for anyone building in biomanufacturing. First, pick the molecule by the incumbent's cost structure, not by market size; a €40-plus per kilo entry point buys you the right to be imperfect at 200 cubic metres, where a €4 per kilo target does not. Second, the binding constraint moves from the fermenter to downstream processing far earlier than most plans assume, and DSP yield is where margin is made or lost. Verley is doing this at a co-manufacturer rather than building its own plant, which is the correct capital decision and also a reminder that European tankage of this size is a scarce, contracted resource: founders who have not secured co-man capacity in writing before raising their scale-up round are negotiating from the weaker side. The regulatory split is worth noting too. US clearance in hand, Europe two to three years out, so the home market is the last one to open. That sequencing is now normal for European novel-food deep tech, and it should be in the plan rather than a surprise in the board pack.

Source: AgFunderNews

Back to AgTech News